Innate Pharma
(IPHYF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 12-2016 | 06-2016 | 12-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 166,088 | 194,650 | 180,560 | 169,630 | 303,940 |
| Marketable Securities | 22,527 | 24,100 | 49,780 | 92,140 | 4,590 |
| Receivables | 26,714 | 35,840 | 23,650 | 17,990 | 17,170 |
| Other current assets | 0 | 10 | 20 | 20 | 20 |
| TOTAL | $215,330 | $254,600 | $254,010 | $279,780 | $325,720 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 46,920 | 56,100 | 52,730 | 5,320 |
| TOTAL | $0 | $46,920 | $56,100 | $52,730 | $5,320 |
| Total Assets | $270,998 | $311,590 | $318,940 | $339,510 | $337,480 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 22,420 | 15,380 | 66,070 | 63,460 |
| Other current liabilities | 0 | 62,160 | 74,120 | 690 | 510 |
| TOTAL | $83,622 | $84,580 | $89,500 | $66,760 | $63,970 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 7,320 | 6,410 | 192,780 | 196,980 |
| TOTAL | $0 | $131,640 | $151,260 | $192,780 | $196,980 |
| Total Liabilities | $195,205 | $216,230 | $240,770 | $259,540 | $260,950 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 2,980 | 3,040 | 2,980 | 2,960 |
| Retained earnings | -113,943 | -128,620 | -131,290 | -121,530 | -121,150 |
| Other shareholders' equity | 189,736 | 13,430 | -4,230 | -8,250 | -8,060 |
| TOTAL | $75,793 | $95,350 | $78,170 | $79,970 | $76,520 |
| Total Liabilities And Equity | $270,998 | $311,580 | $318,940 | $339,510 | $337,470 |